BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 37219410)

  • 1. Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia.
    Brunton S; Pruzin JJ; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
    Postgrad Med; 2023 Jun; 135(5):530-538. PubMed ID: 37219410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.
    Gopalakrishna G; Brunton S; Pruzin J; Alford S; Hamersky C; Sabharwal A
    BMC Psychiatry; 2023 Oct; 23(1):716. PubMed ID: 37794326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists.
    Pruzin JJ; Brunton S; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
    J Prev Alzheimers Dis; 2023; 10(2):162-170. PubMed ID: 36946442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2022 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2022 Apr; 18(4):700-789. PubMed ID: 35289055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
    Nadolsky K; Cryer DR; Articolo A; Fisher T; Schneider J; Rinella M
    Ann Med; 2023 Dec; 55(1):2211349. PubMed ID: 37171239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical journey of patients with polycystic ovary syndrome and obesity: a cross-sectional survey of patients and primary care physicians.
    Sherif K; Coborn J; Hoovler A; Gill L
    Postgrad Med; 2023 Apr; 135(3):312-320. PubMed ID: 36330844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Finding of Mild Cognitive Impairment and Dementia and Subsequent Care; Results of a Cluster RCT in Primary Care.
    van den Dungen P; Moll van Charante EP; van de Ven PM; van Marwijk HW; van der Horst HE; van Hout HP
    PLoS One; 2016; 11(6):e0156958. PubMed ID: 27310616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease Biomarker Decision-Making among Patients with Mild Cognitive Impairment and Their Care Partners.
    Cox CG; Salazar CR; Birnbaum AI; Witbracht M; Tam SP; Thai GT; Sajjadi SA; Gillen DL; Grill JD
    J Prev Alzheimers Dis; 2024; 11(2):285-293. PubMed ID: 38374734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis.
    Tariot PN; Boada M; Lanctôt KL; Hahn-Pedersen J; Dabbous F; Udayachalerm S; Raket LL; Halchenko Y; Michalak W; Weidner W; Cummings J
    Alzheimers Res Ther; 2024 Feb; 16(1):36. PubMed ID: 38355706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2023 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2023 Apr; 19(4):1598-1695. PubMed ID: 36918389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment and dementia in primary care: the value of medical history.
    Olazarán J; Torrero P; Cruz I; Aparicio E; Sanz A; Mula N; Marzana G; Cabezón D; Begué C
    Fam Pract; 2011 Aug; 28(4):385-92. PubMed ID: 21402661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.
    Keine D; Walker JQ; Kennedy BK; Sabbagh MN
    Curr Aging Sci; 2018; 11(3):173-181. PubMed ID: 30338750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.
    Levey A; Lah J; Goldstein F; Steenland K; Bliwise D
    Clin Ther; 2006 Jul; 28(7):991-1001. PubMed ID: 16990077
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.